NCCN VERSION 2 2015

NCCN Guidelines Version 2.2015 Breast Cancer

NCCN Guidelines Index Breast Cancer Table of Contents Discussion

2006;71:456-459. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17690561 .

592. Van Pelt AE, Mohsin S, Elledge RM, et al. Neoadjuvant trastuzumab and docetaxel in breast cancer: preliminary results. Clin

Breast Cancer 2003;4:348-353. Available at: http://www.ncbi.nlm.nih.gov/pubmed/14715110 .

600. Schelfout K, Kersschot E, Van Goethem M, et al. Breast MR imaging in a patient with unilateral axillary lymphadenopathy and unknown primary malignancy. Eur Radiol 2003;13:2128-2132. Available at: http://www.ncbi.nlm.nih.gov/pubmed/12928964 . 601. Bhatia SK, Saclarides TJ, Witt TR, et al. Hormone receptor studies in axillary metastases from occult breast cancers. Cancer 1987;59:1170-1172. Available at: http://www.ncbi.nlm.nih.gov/pubmed/3815292 . 602. Bleicher RJ, Morrow M. MRI and breast cancer: role in detection, diagnosis, and staging. Oncology (Williston Park) 2007;21:1521-1528, 603. Stomper PC, Waddell BE, Edge SB, Klippenstein DL. Breast MRI in the Evaluation of Patients with Occult Primary Breast Carcinoma. Breast J 1999;5:230-234. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11348292 . 604. Buchanan CL, Morris EA, Dorn PL, et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann 1530; discussion 1530, 1532-1523. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18077995 .

593. Boussen H, Cristofanilli M, Zaks T, et al. Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer. Journal of Clinical Oncology 2010;28:3248-3255. Available at: http://jco.ascopubs.org/content/28/20/3248.abstract . 594. Kell MR, Morrow M. Surgical aspects of inflammatory breast cancer. Breast Dis 2005;22:67-73. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16735788 . 595. Stearns V, Ewing CA, Slack R, et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 2002;9:235-242. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11923129 . 596. Motwani SB, Strom EA, Schechter NR, et al. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:76- 82. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16765534 . 597. Blanchard DK, Shetty PB, Hilsenbeck SG, Elledge RM. Association of surgery with improved survival in stage IV breast cancer 598. Olson JA, Morris EA, Van Zee KJ, et al. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol 2000;7:411-415. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10894136 . 599. Varadarajan R, Edge SB, Yu J, et al. Prognosis of occult breast carcinoma presenting as isolated axillary nodal metastasis. Oncology patients. Ann Surg 2008;247:732-738. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18438108 .

Surg Oncol 2005;12:1045-1053. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16244803 .

Version 2.2015, 03/11/15 © National Comprehensive Cancer Network, Inc. 2015, All rights reserved. The NCCN Guidelines® and this illustration may not be reproduced in any form without the express written permission of NCCN®. MS-110